Stratification by PD-L1 TPS in Advanced NSCLC With Low PD-L1 Expression for Optimizing Immunotherapy. Fukui T, Hori S, Hatakeyama Y, Kiriu T, et al. Anticancer Res 2025;45:3859-3875.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fukui T, Hori S, Hatakeyama Y, Kiriu T, et al. Stratification by PD-L1 TPS in Advanced NSCLC With Low PD-L1 Expression for Optimizing Immunotherapy. Anticancer Res 2025;45:3859-3875.
PMID: 40876996